{"2405.08031": {"publish_time": "2024-05-12", "title": "HGTDR: Advancing Drug Repurposing with Heterogeneous Graph Transformers", "paper_summary": "Motivation: Drug repurposing is a viable solution for reducing the time and\ncost associated with drug development. However, thus far, the proposed drug\nrepurposing approaches still need to meet expectations. Therefore, it is\ncrucial to offer a systematic approach for drug repurposing to achieve cost\nsavings and enhance human lives. In recent years, using biological\nnetwork-based methods for drug repurposing has generated promising results.\nNevertheless, these methods have limitations. Primarily, the scope of these\nmethods is generally limited concerning the size and variety of data they can\neffectively handle. Another issue arises from the treatment of heterogeneous\ndata, which needs to be addressed or converted into homogeneous data, leading\nto a loss of information. A significant drawback is that most of these\napproaches lack end-to-end functionality, necessitating manual implementation\nand expert knowledge in certain stages. Results: We propose a new solution,\nHGTDR (Heterogeneous Graph Transformer for Drug Repurposing), to address the\nchallenges associated with drug repurposing. HGTDR is a three-step approach for\nknowledge graph-based drug re-purposing: 1) constructing a heterogeneous\nknowledge graph, 2) utilizing a heterogeneous graph transformer network, and 3)\ncomputing relationship scores using a fully connected network. By leveraging\nHGTDR, users gain the ability to manipulate input graphs, extract information\nfrom diverse entities, and obtain their desired output. In the evaluation step,\nwe demonstrate that HGTDR performs comparably to previous methods. Furthermore,\nwe review medical studies to validate our method's top ten drug repurposing\nsuggestions, which have exhibited promising results. We also demon-strated\nHGTDR's capability to predict other types of relations through numerical and\nexperimental validation, such as drug-protein and disease-protein\ninter-relations.", "paper_summary_zh": "<paragraph>\u52d5\u6a5f\uff1a\u85e5\u7269\u518d\u5229\u7528\u662f\u6e1b\u5c11\u85e5\u7269\u958b\u767c\u6642\u9593\u548c\u6210\u672c\u7684\u53ef\u884c\u89e3\u6c7a\u65b9\u6848\u3002\u7136\u800c\uff0c\u5230\u76ee\u524d\u70ba\u6b62\uff0c\u63d0\u51fa\u7684\u85e5\u7269\u518d\u5229\u7528\u65b9\u6cd5\u4ecd\u9700\u8981\u6eff\u8db3\u9810\u671f\u3002\u56e0\u6b64\uff0c\u63d0\u4f9b\u4e00\u7a2e\u7cfb\u7d71\u6027\u7684\u85e5\u7269\u518d\u5229\u7528\u65b9\u6cd5\u4ee5\u7bc0\u7701\u6210\u672c\u4e26\u6539\u5584\u4eba\u985e\u751f\u6d3b\u81f3\u95dc\u91cd\u8981\u3002\u8fd1\u5e74\u4f86\uff0c\u4f7f\u7528\u57fa\u65bc\u751f\u7269\u7db2\u8def\u7684\u65b9\u6cd5\u9032\u884c\u85e5\u7269\u518d\u5229\u7528\u5df2\u7522\u751f\u4ee4\u4eba\u6eff\u610f\u7684\u7d50\u679c\u3002\u5118\u7ba1\u5982\u6b64\uff0c\u9019\u4e9b\u65b9\u6cd5\u4ecd\u6709\u5c40\u9650\u6027\u3002\u9996\u5148\uff0c\u9019\u4e9b\u65b9\u6cd5\u7684\u7bc4\u570d\u901a\u5e38\u53d7\u5230\u5b83\u5011\u53ef\u4ee5\u6709\u6548\u8655\u7406\u7684\u6578\u64da\u5927\u5c0f\u548c\u7a2e\u985e\u7684\u9650\u5236\u3002\u53e6\u4e00\u500b\u554f\u984c\u6e90\u65bc\u7570\u8cea\u6578\u64da\u7684\u8655\u7406\uff0c\u9700\u8981\u89e3\u6c7a\u6216\u8f49\u63db\u70ba\u540c\u8cea\u6578\u64da\uff0c\u5c0e\u81f4\u4fe1\u606f\u4e1f\u5931\u3002\u4e00\u500b\u91cd\u5927\u7684\u7f3a\u9ede\u662f\uff0c\u9019\u4e9b\u65b9\u6cd5\u5927\u591a\u7f3a\u4e4f\u7aef\u5230\u7aef\u529f\u80fd\uff0c\u9700\u8981\u5728\u67d0\u4e9b\u968e\u6bb5\u9032\u884c\u624b\u52d5\u5be6\u65bd\u548c\u5c08\u5bb6\u77e5\u8b58\u3002\u7d50\u679c\uff1a\u6211\u5011\u63d0\u51fa\u4e86\u4e00\u500b\u65b0\u7684\u89e3\u6c7a\u65b9\u6848\uff0cHGTDR\uff08\u7570\u8cea\u5716\u5f62\u8f49\u63db\u5668\uff0c\u7528\u65bc\u85e5\u7269\u518d\u5229\u7528\uff09\uff0c\u4ee5\u61c9\u5c0d\u8207\u85e5\u7269\u518d\u5229\u7528\u76f8\u95dc\u7684\u6311\u6230\u3002HGTDR \u662f\u4e00\u7a2e\u57fa\u65bc\u77e5\u8b58\u5716\u8b5c\u7684\u85e5\u7269\u518d\u5229\u7528\u7684\u4e09\u6b65\u9a5f\u65b9\u6cd5\uff1a1\uff09\u69cb\u5efa\u7570\u8cea\u77e5\u8b58\u5716\u8b5c\uff0c2\uff09\u5229\u7528\u7570\u8cea\u5716\u5f62\u8f49\u63db\u5668\u7db2\u8def\uff0c\u4ee5\u53ca 3\uff09\u4f7f\u7528\u5b8c\u5168\u9023\u63a5\u7684\u7db2\u8def\u8a08\u7b97\u95dc\u4fc2\u5206\u6578\u3002\u901a\u904e\u5229\u7528 HGTDR\uff0c\u4f7f\u7528\u8005\u53ef\u4ee5\u64cd\u7e31\u8f38\u5165\u5716\u5f62\u3001\u5f9e\u4e0d\u540c\u5be6\u9ad4\u4e2d\u63d0\u53d6\u4fe1\u606f\uff0c\u4e26\u7372\u5f97\u4ed6\u5011\u6240\u9700\u7684\u8f38\u51fa\u3002\u5728\u8a55\u4f30\u6b65\u9a5f\u4e2d\uff0c\u6211\u5011\u8b49\u660e HGTDR \u7684\u8868\u73fe\u8207\u4ee5\u524d\u7684\u65b9\u6cd5\u76f8\u7576\u3002\u6b64\u5916\uff0c\u6211\u5011\u56de\u9867\u4e86\u91ab\u5b78\u7814\u7a76\u4ee5\u9a57\u8b49\u6211\u5011\u7684\u65b9\u6cd5\u4e2d\u6392\u540d\u524d\u5341\u7684\u85e5\u7269\u518d\u5229\u7528\u5efa\u8b70\uff0c\u9019\u4e9b\u5efa\u8b70\u5df2\u5c55\u73fe\u51fa\u4ee4\u4eba\u6eff\u610f\u7684\u7d50\u679c\u3002\u6211\u5011\u9084\u901a\u904e\u6578\u503c\u548c\u5be6\u9a57\u9a57\u8b49\u8b49\u660e\u4e86 HGTDR \u9810\u6e2c\u5176\u4ed6\u985e\u578b\u95dc\u4fc2\u7684\u80fd\u529b\uff0c\u4f8b\u5982\u85e5\u7269-\u86cb\u767d\u8cea\u548c\u75be\u75c5-\u86cb\u767d\u8cea\u7684\u76f8\u4e92\u95dc\u4fc2\u3002</paragraph>", "author": "Ali Gharizadeh et.al.", "authors": "Ali Gharizadeh, Karim Abbasi, Amin Ghareyazi, Mohammad R. K. Mofrad, Hamid R. Rabiee", "id": "2405.08031v2", "paper_url": "http://arxiv.org/abs/2405.08031v2", "repo": "null"}}